Defining a Path Toward the Use of Fast-Scan Cyclic Voltammetry in Human Studies

Area of Science:

• Neuroscience
• Analytical Chemistry
• Biomedical Engineering

Background:

• Fast Scan Cyclic Voltammetry (FSCV) is an established in vivo neurochemical detection method for animal models.
• Recent interest exists in applying FSCV for human neurochemical studies and clinical use.
• Technical limitations currently impede the rigorous and safe clinical implementation of FSCV.

Purpose of the Study:

• To highlight current technical challenges in clinical Fast Scan Cyclic Voltammetry.
• To emphasize the need for pre-clinical studies ensuring accurate neurotransmitter measurement.
• To advocate for a risk management framework for patient safety in clinical FSCV.

Main Methods:

• Review of existing literature on Fast Scan Cyclic Voltammetry applications and limitations.
• Identification of technical barriers to clinical translation.
• Discussion of requirements for ensuring data accuracy, rigor, reproducibility, and patient safety.

Main Results:

• Technical challenges in FSCV limit its current clinical applicability.
• Pre-clinical validation is necessary for accurate neurotransmitter detection in humans.
• A robust risk management framework is essential for patient safety.

Conclusions:

• Addressing technical limitations is paramount for advancing clinical FSCV.
• Rigorous pre-clinical studies and safety assessments are required before widespread human use.
• Collaboration between scientific, engineering, and clinical communities is needed to overcome FSCV implementation barriers.